Find Reports

Select Report Type

Reimbursement Review

Displaying 426 - 450 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Segluromet	ertugliflozin and metformin hydrochloride	SR0566 Segluromet - CDEC Final Recommendation January 25, 2019 for posting.pdf sr0566-segluromet-combined-report.pdf	Diabetes mellitus, Type 2	Do not reimburse	Complete	Apr 30, 2018	Jan 23, 2019	SR0566-000
Lenvima	Lenvatinib	pcodr_profund_lenvatinib_lenvima_rcc_10140.pdf 10140LenvatinibRCC_FnRec_approvedbyChair_Post_04Jan2019_final.pdf 10140LenvatinibRCC_fnCGR_REDACT_Post_04Jan2019_final.pdf 10140LenvatinibRCC_fnEGR_NOREDACT-ABBREV_Post_04Jan2019_final.pdf pcodr_lenvatinib_lenvima_rcc_in_rec.pdf 10140_Lenvatinib_RCC_PAGFeedbackSummary_FINAL_Post_04Jan2019_final.pdf 10140LenvatinibRCC_SubmitterFeedback_2018-11-29_updated_Post_04Jan2019_final.pdf 10140LenvatinibRCC_PatientGroupFeedback_KCC_2018-11-15_Post_04Jan2019_final.pdf 10140LenvatinibRCC_ClinicianFeedback_Combined_Post_04Jan2019_final_Redacted.pdf 10140LenvatinibRCC_COI_KCC_2018-06-22_Post_04Jan2019_draft_Redacted.pdf 10140LenvatinibRCC_Combined_Clinician COIs_Post_04Jan2019_final.pdf	Renal Cell Carcinoma (RCC)	Do not reimburse	Complete	Jun 8, 2018	Jan 4, 2019	PC0140 -000
Tagrisso	Osimertinib	pcodr_provfund_osimertinib_tagrisso_nsclc_1ln.pdf 10137OsimertinibNSCLC_FnRec_2019-01-02_ChairApproved_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC_fnCGR_NOREDACT_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC_fnEGR_NOREDACT-ABBREV_Post_04Jan2019_final.pdf pcodr_osimertinib_tagrisso_nsclc_1stln_in_rec.pdf 10137_Osimertinib_NSCLC_1L_PAGFeedbackSummary_FINAL_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC(firstline)_SubmitterFeedback_2018-11-15_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC(firstline)_PatientGroupFeedback_LCC_2018-11-15_Post_04Jan2019_final.pdf 10137OsimertinibNSCLC(firstline)_ClinicianFeedback_Combined_Post_04Jan2019_Redacted_final_Redacted.pdf 10137OsimertinibNSCLC_COI_LCC_2018-05-31_Post_04Jan2019_final_Redacted.pdf 10137OsimertinibNSCLC_COI Combined_Post_04Jan2019_final.pdf	Non-Small Cell Lung Cancer (NSCLC) (first line)	Reimburse with clinical criteria and/or conditions	Complete	May 16, 2018	Jan 4, 2019	PC0137-000
Velphoro	sucroferric oxyhydroxide	SR0571 Velphoro - CDEC Final Recommendation January 4, 2019 for posting.pdf sr0571-velphoro-clinical-report.pdf sr0571-velphoro-pharmacoeconomic-report.pdf sr0571-velphoro-patient-input.pdf	Hyperphosphatemia, end-stage renal disease	Reimburse with clinical criteria and/or conditions	Complete	Jun 12, 2018	Jan 2, 2019	SR0571-000
Soliqua	lixisenatide + insulin glargine	SR0564 Soliqua - CDEC Final Recommendation January 3, 2019 for posting.pdf sr0564-soliqua-clinical-report.pdf sr0564-soliqua-pharmacoeconomic-report.pdf sr0564-soliqua-patient-input.pdf	Diabetes mellitus, Type 2	Reimburse with clinical criteria and/or conditions	Complete	May 18, 2018	Dec 24, 2018	SR0564-000
Aermony RespiClick	fluticasone propionate	SR0539 Aermony RespiClick - CDEC Final Recommendation for posting December 21, 2018.pdf sr0539-aermony-respiclick-clinical-report.pdf sr0539-aermony-respiclick-pe-report.pdf sr0539-aermony-respiclick-PI-submissions.pdf	Asthma	Reimburse with clinical criteria and/or conditions	Complete	Oct 4, 2017	Dec 19, 2018	SR0539-000
Arbesda RespiClick	fluticasone propionate / salmeterol xinafoate	SR0540 Arbesda RespiClick - CDEC Final Recommendation for Posting December 21, 2018.pdf sr0540-arbesda-respiclick_combined-report.pdf sr0540_arbesda-respiclick_PI_submissions.pdf	Asthma	Reimburse with clinical criteria and/or conditions	Complete	Oct 4, 2017	Dec 19, 2018	SR0540-000
Opdivo	Nivolumab	pcodr_provfund_nivolumab_opdivo_hcc.pdf pcodr_nivolumab_opdivo_hcc_fn_rec.pdf pcodr_nivolumab_opdivo_hcc_fn_cgr.pdf pcodr_nivolumab_opdivo_hcc_fn_egr.pdf pcodr_nivolumab_opdivo_hcc_in_rec.pdf pcodr_nivolumab_opdivo_hcc_pagfdk.pdf pcodr_nivolumab_opdivo_hcc_bmsc.pdf pcodr_nivolumab_opdivo_hcc_clnfdk.pdf pcodr_nivolumab_opdivo_hcc_coi_pt.pdf pcodr_nivolumab_opdivo_hcc_coi_cln.pdf	Metastatic Hepatocellular Carcinoma (HCC)	Do not reimburse	Complete	May 8, 2018	Nov 29, 2018	PC0134-000
Perjeta-Herceptin Combo Pack	Pertuzumab-Trastuzumab Combo Pack	pcodr_provfund_10127perjeta-herceptin-combo_ebc.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_fn_rec.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_fn_cgr.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_fn_egr.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_in_rec.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_pagfdk.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_hlr.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_ptfdk.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_clnfdk.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_coi_pt.pdf pcodr_pertuzumab-trastuzumab_perjeta-herceptin-combo_ebc_coi_cln.pdf	Early Breast Cancer	Do not reimburse	Complete	Apr 9, 2018	Nov 29, 2018	PC0127-000
Xarelto	Rivaroxaban	SR0569 Xarelto - Confidential Final CDEC Recommendation (redacted)_for posting.pdf SR0569_Xarelto_CL_Report.pdf SR0569_Xarelto_PE_Report.pdf	Prevention of stroke and cardiovascular events in coronary and peripheral artery disease.	Reimburse with clinical criteria and/or conditions	Complete	May 24, 2018	Nov 20, 2018	SR0569-000
Opdivo in combination with Yervoy	Nivolumab in combination with Ipilimumab	pcodr_profund_10132opdivo-yervoy_rcc.pdf pcodr_opdivo_yervoy_rcc_fn_rec.pdf pcodr_opdivo_yervoy_rcc_fn_cgr.pdf pcodr_opdivo_yervoy_rcc_fn_egr.pdf pcodr_opdivo_yervoy_rcc_in_rec.pdf pcodr_opdivo_yervoy_rcc_pagfdk.pdf pcodr_opdivo_yervoy_rcc_fdk_bms.pdf pcodr_opdivo_yervoy_rcc_clnfdk.pdf pcodr_opdivo_yervoy_rcc_coi_pt.pdf pcodr_opdivo_yervoy_rcc_coi_cln.pdf	Advanced or Metastatic Renal Cell Carcinoma (RCC).	Reimburse with clinical criteria and/or conditions	Complete	Apr 26, 2018	Nov 1, 2018	PC0132-000
Gazyva	Obinutuzumab	pcodr_provfund_10126obinutuzumab_gazyva_fl_preun.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_rec.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_cgr.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_egr.pdf pcodr_obinutuzumab_gazyva_fl_preun_in_rec.pdf pcodr_obinutuzumab_gazyva_fl_preun_pagfdk.pdf pcodr_obinutuzumab_gazyva_fl_preun_fdk_hlr.pdf pcodr_obinutuzumab_gazyva_fl_preun_clnfdk.pdf pcodr_obinutuzumab_gazyva_fl_preun_coi_pt.pdf pcodr_obinutuzumab_gazyva_fl_preun_coi_cln.pdf	Follicular Lymphoma (previously untreated)	Do not reimburse	Complete	Mar 15, 2018	Nov 1, 2018	PC0126-000
Erleada	Apalutamide	pcodr_provfund_apalutamide_erleada_nm-cprc.pdf pcodr_apalutamide_erleada_crpc_fn_rec.pdf pcodr_apalutamide_erleada_crpc_fn_cgr.pdf pcodr_apalutamide_erleada_crpc_fn_egr.pdf pcodr_apalutamide_erleada_crpc_in_rec.pdf pcodr_apalutamide_erleada_crpc_pagfdk.pdf pcodr_apalutamide_erleada_crpc_fdk_janssen.pdf pcodr_apalutamide_erleada_crpc_ptfdk.pdf pcodr_apalutamide_erleada_crpc_clnfdk.pdf pcodr_apalutamide_erleada_crpc_coi_pt.pdf pcodr_apalutamide_erleada_crpc_coi_cln.pdf	non-metastatic castrate resistant prostate cancer (nm-CRPC)	Reimburse with clinical criteria and/or conditions	Complete	Apr 16, 2018	Nov 1, 2018	PC0133-000
Biktarvy	bictegravir/emtricitabine/tenofovir alafenamide	SR0567 Biktarvy - CDEC Final Recommendation October 29, 2018.pdf SR0567_Biktarvy_CL_Report.pdf SR0567_Biktarvy_PE_Report.pdf SR0567_Biktarvy_PI_Submissions.pdf	HIV-1 infection	Reimburse with clinical criteria and/or conditions	Complete	Apr 30, 2018	Oct 25, 2018	SR0567-000
Mavenclad	cladribine	SR0546-Mavenclad_Oct-26-18.pdf SR0546_Mavenclad_CL_Report.pdf SR0546_Mavenclad_PE_Report.pdf SR0546_Mavenclad_PI_Submissions.pdf	Multiple Sclerosis, relapsing-remitting	Reimburse with clinical criteria and/or conditions	Complete	Dec 1, 2017	Oct 24, 2018	SR0546-000
Ozanex	ozenoxacin	SR0553_Ozanex_Oct-26-18.pdf SR0553_Ozanex_CL_Report.pdf SR0553_Ozanex_PE_Report.pdf SR0553_Ozanex_PI_Submissions.pdf	Impetigo	Do not reimburse	Complete	Jan 25, 2018	Oct 24, 2018	SR0553-000
Ozurdex	dexamethasone	SR0535_Ozurdex_Oct-26-18.pdf SR0535_Ozurdex _CL_Report.pdf SR0535_Ozurdex_PE_Report .pdf SR0535_Ozurdex_PI_Submissions.pdf	Diabetic macular edema	Do not reimburse	Complete	Sep 26, 2017	Oct 24, 2018	SR0535-000
Nucynta	tapentadol hydrochloride	SR0563_Nucynta - CDEC Final Recommendation October 25, 2018.pdf SR0563_Nucynta_CL_Report.pdf SR0563_Nucynta_PE_Report.pdf SR0563_Nucynta_PI_Submissions.pdf	pain, severe	Do not reimburse	Complete	Apr 17, 2018	Oct 23, 2018	SR0563-000
Kanuma	sebelipase alfa	SR0544 Kanuma - CDEC Final Recommendation September 28, 2018.pdf SR0544_Kanuma_CL_Report.pdf SR0544_Kanuma_PE_Report.pdf SR0544_Kanuma_PI_Submissions.pdf si0003-kanuma-cadth-drug-implementation-advice.pdf	Lysosomal acid lipase deficiency	Reimburse with clinical criteria and/or conditions	Complete	Nov 2, 2017	Sep 26, 2018	SR0544-000
Orkambi	lumacaftor/ivacaftor	SR0559 Orkambi - CDEC Final Recommendation October 4, 2018.pdf SR0559_Orkambi_CL_Report.pdf SR0559_Orkambi_PE_Report.pdf SR0559_Orkambi_PI_Submissions.pdf	Cystic Fibrosis, F508del CFTR mutation in patients 6 years and older	Do not reimburse	Complete	Feb 22, 2018	Sep 26, 2018	SR0559-000
Viberzi	eluxadoline	SR0560_cdr_complete_Viberzi_Aug_29_18.pdf SR0560_Viberzi_CL_Report.pdf SR0560_Viberzi_PE_Report.pdf SR0560_Viberzi_PI_Submissions.pdf	Irritable bowel syndrome with diarrhea	Do not reimburse	Complete	Feb 23, 2018	Aug 24, 2018	SR0560-000
Dysport Therapeutic	abobotulinumtoxinA	SR0556_Dysport_Therapeutic_Aug_23_18.pdf SR0556_Dysport_Therapeutic_CL_Report.pdf SR0556_Dysport_Therapeutic_PE_Report.pdf SR0556_Dysport_PI_Submissions.pdf	lower limb spasticity	Reimburse with clinical criteria and/or conditions	Complete	Feb 7, 2018	Aug 23, 2018	SR0556-000
Trelegy Ellipta	fluticasone furoate umeclidinium vilanterol	SR0562_cdr_complete_Trelegy_Ellipta_Aug_27_18.pdf SR0562_TrelegyEllipta_CL_Report.pdf SR0562_TrelegyEllipta_PE_Report.pdf SR0562_TrelegyEllipta_PI_Submissions.pdf	Chronic obstructive pulmonary disease (COPD)	Reimburse with clinical criteria and/or conditions	Complete	Mar 1, 2018	Aug 23, 2018	SR0562-000
Nitisinone	nitisinone	SR0554_Nitisinone_Aug_23_18.pdf SR0554_Nitisinone_CL_Report.pdf SR0554_Nitisinone_PE_Report.pdf SR0554_Nitisinone_PI_Submissions.pdf	Hereditary tyrosinemia type 1	Reimburse with clinical criteria and/or conditions	Complete	Jan 25, 2018	Aug 23, 2018	SR0554-000
Probuphine	buprenorphine hydrochloride	SR0550_Probuphine_Aug_24_18.pdf SR0550_Probuphine_CL_Report.pdf SR0550_Probuphine_PE_Report.pdf	Opioid drug dependence, treatment	Reimburse with clinical criteria and/or conditions	Complete	Dec 21, 2017	Aug 22, 2018	SR0550-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 426 - 450 of 589

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Dialectical Behaviour Therapy for People with Borderline Personality Disorder: A Rapid Qualitative Review	RC1320 DBT for BPD qual Final.pdf	Nov 26, 2020	Summary with Critical Appraisal	Completed	RC1320-000
PET Diagnostic Imaging with Prostate-Specific Membrane Antigen for Prostate Cancer: A Review of Clinical Utility, Cost-Effectiveness, Diagnostic Accuracy, and Guidelines	RC1321 PSMA for Prostate Cancer Final.pdf	Nov 26, 2020	Summary with Critical Appraisal	Completed	RC1321-000
Trastuzumab Combination and Monotherapy for HER2 Advanced or Recurrent Uterine or Endometrial Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness	RC1319 Trastuzumab for USC Final.pdf	Nov 26, 2020	Summary with Critical Appraisal	Completed	RC1319-000
Target-Controlled Infusion with Propofol and Remifentanil for Moderate Procedural Sedation in Medicine and Dentistry: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1315 TCI with Propofol and Remifentanil Final.pdf	Nov 16, 2020	Summary with Critical Appraisal	Completed	RC1315-000
Care for Acquired Brain Injury and Concurrent Mental Health and Substance Use Issues		Nov 5, 2020			ES0339-000
Patient Positioning During a Hypotensive Episode for Adults Undergoing Hemodialysis: A Review of Clinical Effectiveness and Guidelines	RC1308 Patient Positioning during Hemodialysis Final.pdf	Nov 2, 2020	Summary with Critical Appraisal		RC1308-000
Outpatient or Short Stay Total Hip or Knee Arthroplasty versus Conventional Total Hip or Knee Arthroplasty: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines	Outpatient or Short Stay Total Hip or Knee Arthroplasty versus Conventional Tot…	Oct 28, 2020	Summary with Critical Appraisal	Completed	RC1313-000
Intravenous Multivitamin Therapy Use in Hospital or Outpatient Settings: A Review of Clinical Effectiveness and Guidelines	RC1310 IV Multivitamins Final.pdf	Oct 26, 2020	Summary with Critical Appraisal		RC1310-000
Rapid Point-of-Care Antigen Testing for SARS-CoV-2 Infection	Rapid Point-of-Care Antigen Testing for SARS-CoV-2 Infection	Oct 20, 2020	Health Technology Update		EN0025-000
Care for Acquired Brain Injury and Concurrent Mental Health Conditions and/or Substance Use Disorders	es0339-care-for-acquired-brain-injury.pdf	Oct 15, 2020			ES0339-000
Transcatheter Aortic Valve Implantation for Degenerated Mitral or Tricuspid Bioprostheses: A Review of Clinical Effectiveness and Cost-Effectiveness	RD0057 TAVI 2 Final.pdf	Oct 13, 2020	Peer-reviewed Summary with Critical Appraisal	Completed	RD0057-000
Ventilation and Perfusion Imaging for the Diagnosis of Pulmonary Embolisms During the COVID-19 Pandemic: A Review of Safety and Guidelines	Ventilation and Perfusion Imaging for the Diagnosis of Pulmonary Embolisms Duri…	Oct 6, 2020	Rapid Review	Completed	RC1309-000
Wearable Devices for Monitoring and Detecting COVID-19 Symptoms	Wearable Devices for Monitoring and Detecting COVID-19 Symptoms	Sep 30, 2020	Health Technology Update	Completed	EN0021-000
Interventions for the Prevention of Sudden Infant Death Syndrome and Sudden Unexplained Death in Infancy: A Review of Guidelines	RC1307 SIDS Prevention Final.pdf	Sep 28, 2020	Summary with Critical Appraisal		RC1307-000
Flash Glucose Monitoring System FreeStyle Libre to Monitor Glycemia in Patients With Diabetes	ho0009-tech-review-flash-glucose-monitoring-system-freestyle-libre.pdf ho0009-fgms-implementation-advice-report.pdf	Sep 24, 2020	Technology Review	Completed	HO0009-000
Nusinersen for Adolescents and Adults with Spinal Muscular Atrophy: A Review of Clinical Effectiveness	RD0056 Spinraza for SMA Final.pdf	Sep 22, 2020	Rapid Review with Expert Input	Completed	RD0056-000
Fecal Microbiota Therapy in Canada: Barriers and Facilitators to Access		Sep 17, 2020	Environmental Scan	Completed	ES0341-000
Fecal Microbiota Therapy in Canada: An Environmental Scan		Sep 17, 2020	Environmental Scan	Completed	ES0341-000
Enablers for Virtual Visits	Enablers for Virtual Visits	Sep 4, 2020	Policy Insight	Completed	CY0006-000
Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement: A Review of Clinical Effectiveness and Guidelines	RC1304 ASA for VTE Final.pdf	Aug 31, 2020	Summary with Critical Appraisal		RC1304-000
Hypodermoclysis for Frail Patients and Patients in Long Term Care: A Review of Clinical Effectiveness, Cost Effectiveness, and Guidelines	Hypodermoclysis for Frail Patients and Patients in Long Term Care: A Review of …	Aug 31, 2020	Summary with Critical Appraisal	Completed	RC1306-000
Comparative Assessment of Coverage Criteria for Biologic Disease-Modifying Antirheumatic Drugs Across Canadian Public Drug Plans: An Environmental Scan		Aug 27, 2020			ES0351-000
Immediately Sequential Bilateral Cataract Surgery for the Treatment of Bilateral Cataracts: A Review of Safety and Guidelines	media:document:4bb2d7e7-a61a-4e25-b2dc-d88d44011da5	Aug 25, 2020	Summary with Critical Appraisal		RC1305-000
Technologies to Address the Negative Effects of Social Isolation for Older Adults Living in Long-Term Care	Technologies to Address the Negative Effects of Social Isolation for Older Adul…	Aug 17, 2020	Health Technology Update	Completed	EN0024-000
Sex Offender Treatment Programs Delivered In-Person or Virtually for Adults Convicted of Sexual Offences in Various Settings: A Review of Clinical Effectiveness and Guidelines	RC1300 Sex Offender Treatment Final.pdf	Aug 17, 2020	Summary with Critical Appraisal		RC1300-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 426 - 450 of 2093

Please scroll or swipe to the right to view the full content.

Title	Description	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Photon-Counting CT: High Resolution, Less Radiation	CT scanners play an essential role as medical imaging devices for screening, diagnosis, and monitoring of various health conditions. Photon-counting CT (PCCT) is an emerging medical technology that can improve image quality with less radiation exposure.	La tomodensitométrie à comptage photonique améliore la résolution et réduit l’irradiation	Mar 4, 2024	Horizon Scan	Emerging Health Technologies	Completed	EH0124-000
CADTH Pharmaceutical Reviews Update — Issue 44			Feb 29, 2024	Reimbursement Review	Pharmaceutical Review Update
polatuzumab vedotin		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Feb 28, 2024	Reimbursement Review		Complete	PC0313-000
Cost-Effectiveness of Respiratory Syncytial Virus Vaccines for Adults		Cost-Effectiveness of Respiratory Syncytial Virus Vaccines for Adults	Feb 26, 2024	Health Technology Review	Technology Review	Completed	HE0047 -000
Timing of Antibiotic Therapy for Neisseria Gonorrhoeae Infection		Timing of Antibiotic Therapy for Neisseria Gonorrhoeae Infection	Feb 24, 2024	Health Technology Review	Rapid Review	Completed	RC1527-000
Clinical and Instrumental Swallowing Assessments for Dysphagia		Clinical and Instrumental Swallowing Assessments for Dysphagia	Feb 23, 2024	Health Technology Review	Rapid Review	Completed	RC1526-000
Renal cell carcinoma		Final Report	Feb 21, 2024	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0037-000
cabozantinib		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 15, 2024	Reimbursement Review		Complete	PC0312-000
Calcitonin Gene-Related Peptide Inhibitors for Migraine Prophylaxis			Feb 12, 2024	Health Technology Review	Technology Review	In Progress	HC0081-000
elexacaftor/tezacaftor/ivacaftor and ivacaftor		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 9, 2024	Reimbursement Review		Complete	SR0776-000
mirikizumab		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 9, 2024	Reimbursement Review		Complete	SR0773-000
ibrutinib		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 9, 2024	Reimbursement Review		Complete	PC0317-000
Average Volume of MRI Exams Conducted per Hour Across Canada	Using data from the national Canadian Medical Imaging Inventory 2019 to 2020 survey, we calculated an average of MRI exams performed per hour across Canada	Average Volume of MRI Exams Conducted per Hour Across Canada	Jan 31, 2024	Health Technology Review	CMII Service	Completed	CM0008-000
Biologic Drugs for Severe Asthma		Final Report Summary Report	Jan 30, 2024	Health Technology Review	Technology Review	Completed	RE0047-000
Buprenorphine Formulations for Opioid Use Disorder		Buprenorphine Formulations for Opioid Use Disorder	Jan 30, 2024	Health Technology Review	Systematic Review	Completed	RE0051-000
nelarabine		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Jan 26, 2024	Reimbursement Review		Complete	PC0307-000
CADTH Pharmaceutical Reviews Update — Issue 43			Jan 25, 2024	Reimbursement Review	Pharmaceutical Review Update
durvalumab and tremelimumab		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Jan 25, 2024	Reimbursement Review		Complete	PC0308-000
The Safety of Niraparib in Ovarian Cancer	To give clinicians and policy-makers a better understanding of the niraparib’s risk profile, researchers conducted an observational study to look at how the safety and tolerability of niraparib in the real world compares with observations from seminal clinical trials.	Summary Report for Policy-Makers Summary Report for Clinicians Plain Language Summary Report Observational Study - The Safety of Niraparib in Ovarian Cancer Final Protocol	Jan 24, 2024	Health Technology Review	Observational Study	Active	OS0002-000
Unresectable Hepatocellular Carcinoma		Final Report	Jan 24, 2024	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0036-000
Chatbots in Health Care: Connecting Patients to Information		Chatbots in Health Care: Connecting Patients to Information	Jan 24, 2024	Horizon Scan	Emerging Health Technologies	Completed	EH0122-000
Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update	We conducted a review of the clinical effectiveness, cost-effectiveness, and evidence-based guidelines on the use of ketamine in adults with TRD or PTSD, to help guide decisions on the use of ketamine for managing these conditions.	Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update	Jan 23, 2024	Health Technology Review	Rapid Review	Completed	RC1522-000
axicabtagene ciloleucel		Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	Jan 22, 2024	Reimbursement Review		Complete	PG0314-000
Endobronchial Valves for the Management of Severe Emphysema		Endobronchial Valves for the Management of Severe Emphysema	Jan 18, 2024	Health Technology Review	Rapid Review	Completed	RC1524-000
Ketorolac for Renal Colic		Ketorolac for Renal Colic	Jan 18, 2024	Health Technology Review	Rapid Review	Completed	RC1525-000